Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China

Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China

The objective of this study was to investigate the current situation of vancomycin (VAN)-associated acute kidney injury (VA-AKI) in China and identify the risk factors for VA-AKI, as well as to comprehensively examine the risk related to concurrent drug use. Further, the investigators assessed the outcomes of patients who developed VA-AKI and the risk factors for these outcomes. Finally, the investigators aimed to provide suggestions for improving the prevention and treatment of VA-AKI in China.

Inclusion Criteria:

• Using Vancomycin
• ≥18 years old

Exclusion Criteria:

• Medical records were incomplete
• Had been diagnosed with stage 5 CKD or were regularly receiving dialysis
• SCr were not being adequately monitored to detect the development of AKI
• Had undergone nephrectomy